Plain-English translation of NCT06871176 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new type of imaging scan called PET/MR that may help doctors better find and monitor multiple myeloma, a cancer of bone marrow cells. The scan works by looking for specific markers on cancer cells. Researchers want to see if this new scan is better than the standard imaging tests doctors currently use.
Multiple myeloma can be hard to detect and monitor with current imaging methods, and patients often need multiple different scans. This trial is trying to find out if a single combined scan could give doctors better information about the disease while reducing the burden on patients.
You likely qualify if…
You likely don't qualify if…
You would undergo the new PET/MR imaging scan in addition to standard imaging tests so researchers can compare how well each scan detects your disease. The study includes initial staging to help plan your treatment and follow-up scans to monitor how you respond to therapy. The exact number of visits and duration will depend on your treatment timeline.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Canada